Microbial strains with a unique combination of technological and bioactive properties are preferred for industrial applications. The present study was conducted to evaluate the potential use of
Enterococcus mundtii
QAUEM2808 (NCBI Accession Number:
LSMC00000000
) in milk fermentation. This strain was isolated from Dahi, an indigenous fermented milk product of South-East Asia. The
in vitro
study confirmed the acidification ability as well as the proteolytic, cellulolytic, and amylolytic enzyme activities of this strain. It also produced a substantial amount of the folate in laboratory media and no physiological dysfunctions in laboratory animals was observed in feeding trials. All these properties were confirmed by
in silico
genome analysis. The
Enterococcus mundtii
QAUEM2808 genome consisted of a single, circular chromosome comprising 2,957,300-bp, 2,587 genes with GC content of 38.5%. Moreover, 16t RNAs, 1, 3 (16S, 23S) rRNAs, 4 ncRNAs, and 91 pseudo genes were also predicted. The majority of genome encode genes for protein, amino acids, carbohydrate, cell wall DNA and RNA metabolisms including all genes required for conversion of lactose to lactic acid. It also exhibited antimicrobial activity against
E. coli
ATCC 10536,
S. aureus
ATCC 6538,
P. aeruginosa
ATCC 9027, and
L. monocytogenes
ATCC 13932 and was found to be sensitive to commonly used antibiotics. The
in silico
analysis revealed the presence of genes for mundaticin and enterocin production, and CRISPER regions, however, the genes for antibiotic resistance were absent. No genes related to the pathogenicity island and prophages were detected by genome mining. Therefore, it could be inferened that
Enterococcus mundtii
QAUEM2808 has the potential to be used in milk fermentation as adjunct culture.